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A B S T R A C T
The icosahedral capsid structure of simian virus 40 (diameter, 45nm) consists of 72 pentameric subunits,
with each subunit formed by ﬁve VP1 molecules. Electron microscopy, immuno-gold labeling, and
z-potential analysis showed that puriﬁed recombinant VP1 pentamers covered polystyrene beads
measuring 100, 200, and 500nm in diameter, as well as silica beads. In addition to covering spherical
beads, VP1 pentamers covered cubic magnetite beads, as well as the distorted surface structures of
liposomes. These ﬁndings indicate that VP1 pentamers could coat artiﬁcial beads of various shapes and
sizes larger than the natural capsid. Technology based on VP1 pentamers may be useful in providing a
capsid-like surface for enclosed materials, enhancing their stability and cellular uptake for drug delivery
systems.
ã 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Simian virus 40 (SV40) is a small non-enveloped DNA virus of
the Polyomaviridae family. Its capsid is 45nm in diameter and is
formed by 72 pentameric subunits, each composed of ﬁve
VP1major capsid proteins (360molecules in total). VP1 pentamers
are arranged in a T =7d (triangulation number 7 dextro)
icosahedral lattice, with the carboxyl terminus of VP1 mediating
inter-pentameric contacts that hold the capsid together [1].
VP1 pentamers can be arranged in both ﬁve-fold and six-fold
rotational positions on the icosahedral lattice of the SV40 capsid
structure. Hence, the SV40 capsid is unique in that the icosahedral
lattice can be formed by VP1 pentamers alone. By contrast, capsids
of other viruses, such as the adenovirus capsid, are composed of
pentamer and hexamer protein subunits.
When expressed in insect cells using recombinant baculovirus,
VP1 self-assembles into virus-like particles (VLPs) (45nm in
diameter), similar to the natural assembly of SV40 virus capsids
[2,3]. Incubation in vitro of VLPs isolated from these cells with
dithiothreitol (DTT) and ethylene glycol-bis(2-aminoethylether)-
N,N,N0,N0-tetraacetic acid (EGTA) results in their disassembly into
VP1 pentamers [4]. These VP1 pentamers can self-reassemble
in vitro into VLPs under appropriate conditions [5,6]. During
reassembly, VLPs can encapsidate variousmaterials, including DNA
[7,8] and proteins [9], suggesting that SV40-VLPs may be a
promising platform for drug delivery systems. Additionally,
VP1 may be modiﬁed to target speciﬁc cells. Foreign peptides
[10] and human epidermal growth factor (EGF) [11] were inserted
into VP1. Moreover, citrate-coated magnetic nanoparticles
(CMNPs) were coated with VP1 pentamers, followed by
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conjugation of EGF protein (EGF-VP1-CMNPs) [7]. VP1 coating was
found to greatly enhance the mono-dispersibility of CMNPs under
physiological conditions, and in serum containing buffer, prolong-
ing their retention in body ﬂuids, whereas conjugation of EGF
selectively guided these CMNPs onto EGF receptor expressing cells.
Inclusion of EGF-VP1-CMNPs in contrast agent for magnetic
resonance imaging may enhance the visualization of tumor cells
overexpressing EGF receptor in vivo. Other VLPs can also be utilized
to modify natural nanoparticles, allowing their use as contrast
agents for medical imaging [12]. VLPs may also be a promising
vaccine platform [13,14]. Thus, VP1 has great potential in the
development of a variety of medical nanomaterials.
Capsid subunits of various viruses were used to encapsidate
artiﬁcial beads. For example, the capsid protein of a plant virus, red
clover necrotic mosaic virus (RCNMV), was used to encapsidate
gold nanoparticles. In that study, the surface of gold nanoparticles
was immobilized with an RNA sequence to which RCNMV capsid
protein binds speciﬁcally, resulting in RCNMV capsid protein
being concentrated on the surface of the particles [15].
SV40 VP1 pentamers were used to encapsidate unmodiﬁed
artiﬁcial beads, including quantum dot [16] and gold nanoparticles
[17]. However, the importance of the structural conditions of
materials encapsidated by viral capsid proteins has not been
extensively studied.
This study shows that various artiﬁcial beads could be coated
with VP1 pentamers, with no particular limitation of the sizes
and shapes of coated artiﬁcial beads. These results indicate
that VP1 coating technology is applicable to a variety of
materials, providing capsid-like surface conditions and enabling
high dispersibility and stability even in body ﬂuids. Highly
dispersible and stable materials coated by VP1 pentamers may
be promising materials for diagnosis and treatment of various
illness/diseases.
2. Materials and methods
2.1. Preparation of VP1 pentamers
VLPs consisting of wild-type VP1 were prepared as described
[4]. Brieﬂy, recombinant baculovirus expressing VP1 was generat-
ed using the baculovirus expression system (Invitrogen). Sf-9 cells
were infected with these viruses, and VLPs were puriﬁed from
lysates of these cells by cesium chloride density gradient. The VLPs
were dialyzed in buffer containing 20mM Tris–HCl (pH 7.9),
150mM NaCl, and 0.1% Nonidet P-40 (NP-40), and puriﬁed VLPs
were dissociated in buffer containing 20mM Tris–HCl (pH 7.9),
150mMNaCl, 5mMDTT, and 5mM EGTA. The dissociated samples
were fractionated bygel ﬁltration (Superdex 200, GEHealthcare) in
the same buffer to yield monomeric VP1 pentamers.
2.2. Polystyrene and silica beads
Polystyrene beads (Polybead@Carboxylate 0.10 Micron Micro-
spheres) were purchased from Polysciences, Inc. Silica beads
(silica-coated CMNPs) were prepared using the seeded polymeri-
zation technique with sol–gel reaction. Brieﬂy, a solution of
tetraethyl orthosilicate (TEOS) in ethanol was added to the CMNPs
in water. Silica coating was initiated by rapidly injecting an
aqueous ammonia solution into the CMNP–TEOS mixture so that
the water concentration of the dispersion mediumwas 11.0M (1:4
(v/v) water/ethanol) and stirred overnight at 4 C. The concentra-
tion of TEOS was varied from 2.5 to 44.1mM, resulting in iron and
ammonia concentrations of 3.6mM and 0.9M, respectively.
Double-distilled water was added to the mixture, followed by
evaporation to remove ethanol and ammonia. The resulting
mixture was dialyzed against double-distilled water to obtain
puriﬁed silica beads. CMNPs were prepared as described [18]. The
average diameter of silica beads (110nm) in solution was
determined using ELSZ-2 (Otsuka Electronics Co., Ltd.).
2.3. Citric-acid-coated cubic magnetite beads
To synthesize cubic magnetite beads, the iron oleate complex
was dissolved in tri-n-octylamine (190g) containing oleic acid
(6.14 g). Themixturewas gradually heated to boiling with vigorous
stirring and maintained at that temperature for 30min. The
mixture was cooled to room temperature, and a large excess of
2-propanol was added, followed by centrifugation at 7500 rpm for
1h and redispersion in 1-octadecene. For citric-acid coating,
prepared magnetite particles (180mg) were washed with
2-propanol and suspended in toluene (16ml). After washing, the
suspension was mixed with 4ml dimethyl sulfoxide (DMSO)
containing 0.3 g of thiomalic acid and sonicated at 35kHz for 4h
under a nitrogen atmosphere. The resulting black precipitate was
washed with 2-methoxyethanol and dispersed in an aqueous
solution of sodium citrate. The dispersed mixture was then
sonicated at 35kHz for 1h. The resultant magnetite beads were
precipitated by adding 1,4-dioxane and separated using a magnet.
Finally, citric-acid-coated cubic magnetite beads were dispersed in
distilled water and dialyzed for 3h. The average length per side of
ten randomly selected cubic magnetite beads on electron
micrographs was approximately 30nm. The average diameters
of uncoated and VP1-coated cubic magnetite beads in solution
were determined using ELSZ-2 (Otsuka Electronics Co., Ltd.).
2.4. Poly-lactic-co-glycolic-acid (PLGA) beads
Ten microliters of N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-
trimethyl ammonium chloride (DOTAP) in water (5mg/ml) was
added to 400ml of PLGA in acetone (25mg/ml) to generate a water
in oil (W/O) emulsion. To this mixture was added 5ml of 2%
polyvinyl alcohol (PVA) in water under vortex to generate a water
in oil in water (W/O/W) double emulsion. The latter was
centrifuged at 15,000 rpm for 10min at 4 C, and the supernatant
was removed. The resultant pellet was resuspended in 2ml of
water and stirred overnight at 4 C to produce puriﬁed PLGA beads.
The average diameter of PLGA beads (200nm) in solution was
determined using ELSZ-2 (Otsuka Electronics Co., Ltd.).
2.5. Preparation of cationic liposome particles
DOTAP and 1,2-dioleoyl-sn-glocero-3-phosphoethanolamine
(DOPE) (3:1 molar ratio) were diluted in chloroform at a lipid
concentration of 5mg/ml. To prepare a lipid ﬁlm, chloroform was
allowed to evaporate under nitrogen ﬂow. The ﬁlmwas rehydrated
in Tris–HCl buffer by intermittent vortexing, and extruded through
a polycarbonate ﬁlter (pore size, 100nm) using a Mini Extruder
(Avanti Polar Lipids).
2.6. VP1 coating of artiﬁcial beads and electron microscopy (EM)
Puriﬁed monomeric VP1 pentamers were mixed with artiﬁcial
polystyrene, silica, PLGA, or citric-acid-coated cubic magnetite
beads, or cationic liposomes, at a ratio of approximately 104:1.
Each mixture was dialyzed in coating buffer, containing 20mM
MOPS–NaOH (pH 7.0), 150mM NaCl, and 2mM CaCl2, for 16h at
room temperature. To remove free VP1 pentamers, the samplewas
centrifuged at 2,0400 g for 15min at 4 C. The pellet fraction
containing VP1-coated beads was washed twice and resuspended
in coating buffer. For transmission electron microscopy (TEM),
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the samples were negatively stained with 2% ammonium
molybdate and examined under a TEM (H-7500, Hitachi) as
described [4].
2.7. Immuno-gold labeling of VP1-caoted polystyrene or silica beads
Artiﬁcial beads, either uncoated or coated with
VP1 pentamers, were incubated with anti-VP1 antibody for 1 h
at 37 C, followed by incubation with protein-A-conjugated
colloidal-gold (EM.PAG10, British BioCell International, Ltd.) for
1 h at 37 C. The samples were negatively stained and examined
under a TEM, as described above.
2.8. z potential of VP1-coated artiﬁcial beads
Uncoated and VP1-pentamer coated artiﬁcial beads were
measured with ELSZ-2 (Otsuka Electronics Co., Ltd.) and dialyzed
against buffers of pH 5, 7, and 9 using mini-dialysis units with a
molecular weight cutoff of 3500Da (Pierce, Rockford, IL).
3. Results
3.1. VP1-pentamer covered polystyrene beads
Our previous studies showed that the diameter of the particles
induced by DNA-mediated self-assembly of VP1 in vitro was
approximately 45nm [8], and that CMNPs, 8, 20 and 27nm in
diameter, were completely encapsulated by VP1 pentamers [18],
suggesting that packaging is achieved when particle diameter is
under 45nm.
To determine the size limitations of artiﬁcial beads encapsulat-
ed by VP1 pentamers, packaging reactions were performed using
polystyrene beads (100nm and 200nm in diameter).
VP1 pentamers were mixed with polystyrene beads and dialyzed
against a physiological buffer containing 20mMMOPS–NaOH (pH
7.0), 150mM NaCl, and 2mM CaCl2 for 16h at room temperature.
After dialysis, the mixture was washed once, and a portion of the
resuspended sample was mounted onto a collodion-coated copper
grid and negatively stained with 2% ammoniummolybdate for EM
(Fig. 1A and B). Surprisingly, these polystyrene beads (100nm and
200nm in diameter) were covered by VP1 pentamers.
To conﬁrm that the VP1 pentameric structure occupying the
entire surface of these beads was composed of VP1 proteins, the
dialyzed sample on the EM grid was incubated with anti-
VP1 antibody, followed by immuno-gold labeling (Fig. 1C). As
expected, gold particles accumulated on the surface of VP1-
pentamer coated, but not uncoated, polystyrene beads, indicating
that the polystyrene beads were covered by VP1 pentamers.
3.2. z potential of polystyrene beads covered by VP1 pentamers
To support this ﬁnding, the z potential of polystyrene beads
before and after VP1 coating was analyzed. The z potential is the
potential difference between the buffer and the stationary layer of
ﬂuid attached to the dispersed bead. Therefore, when polystyrene
beads are coveredwith VP1 pentamers, the z potential of the beads
would be moderated and closer to that of wild-type VLP. To verify
this, the surface potential of VLPwas assessed at pH 5, 7, and 9. This
surface potential was 10mV at pH 5, declining to 30mV at pH 9,
indicating that the electron charge on the functional groups of
VP1 was altered by pH (Fig. 2A). By contrast, the surface potentials
of uncoated polystyrene beads (100nm, 200nm, and 500nm in
diameter) ranged from 35 to 45mV (Fig. 2B, open circles),
30 to35mV (Fig. 2C, open circles), and55 to65mV (Fig. 2D,
open circles), respectively. These ﬁndings indicated that the z
potentials of the polystyrene beads were lower than that of
wild-type VLP from pH 5 to pH 9. The z potential of uncoated
polystyrene beads remained almost unchanged from pH 5 to pH
9 because the functional groups of these beads consist only of
phenol residues, the electric charge of which is not altered in this
pH range. When polystyrene beads (100nm, 200nm, and 500nm
in diameter) were covered with VP1 pentamers, however, their z
potentials between pH 5 and pH 9 ranged from 5 to 25mV
(Fig. 2B, closed circles), 25 to 25mV (Fig. 2C, closed circles), and
15 to 25mV (Fig. 2D, closed circles). Thus, coating with
VP1 pentamers altered the z potential of polystyrene beads,
making the z potentials closer to those of VLPs. These ﬁndings also
indicate that polystyrene beads as large as 500nm in diameter can
be coated with VP1 pentamers. The differences in z potentials of
the three sizes of VP1-pentamer-coated polystyrene beads may be
due to differences in the proportion of superﬁcial area per unit
volume of these three bead sizes.
[(Fig._1)TD$FIG]
Fig.1. VP1 coating of polystyrene beads. A and B, polystyrene beads, (A) 100nm and
(B) 200nm in diameter, were incubated with (right) or without (left)
VP1 pentamers during dialysis. The samples were visualized by TEM with negative
staining. (C) polystyrene beads incubated with (right) or without (left)
VP1 pentamers were mounted on an EM grid, followed by incubation with anti-
VP1 antibody and protein-A-conjugated colloidal-gold. The EM grid was observed
by TEM. Scale bars: 100nm and 25nm (insets).
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Fig. 2. z potential of VP1-coated and uncoated polystyrene beads of various diameters. z potential of (A) wild-type VLP and (B) 100nm, (C) 200nm, and (D) 500nm
polystyrene beads with or without VP1 pentamers in buffers of pH 5, 7, and 9. Data are shown as the mean of the three independent experiments; error bars indicate one
standard deviation.
[(Fig._3)TD$FIG]
Fig. 3. VP1 coating of silica beads. A, silica beads were incubated with (right) or without (left) VP1 pentamers during dialysis. The samples were visualized by TEM with
negative staining. Scale bars: 100nmor 25nm (insets). B, silica beads incubatedwith (right) orwithout (left) VP1 pentamersweremounted onto EM grids and incubatedwith
anti-VP1 antibody, followed by protein-A-conjugated colloidal-gold. The sampleswere visualized by TEM. Scale bars: 100nm or 25nm (insets). C, z potential of wild-type VLP
(left) and silica beads with or without VP1 pentamers (right). Data are the mean of three independent experiments; error bars indicate one standard deviation.
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3.3. VP1 coating of silica beads
To determine whether the surface conditions of artiﬁcial beads
affects their coating with VP1 pentamers, the ability of these
pentamers to coat silica beads was assessed. In contrast to
polystyrene beads, which have phenol residues unaffected by pH
as functional groups, silica beads have hydroxyl groups, the electric
charge of which is altered by pH. After coating with
VP1 pentamers, TEM showed the pentameric structure on the
surface of silica beads (Fig. 3A). Immuno-gold labeling showed the
presence of gold particles on VP1-pentamer-coated silica beads
after incubation with anti-VP1 antibody (Fig. 3B).
The z potential of uncoated silica beads was 180mV at pH 5,
decreasing to 120mV at pH 9, indicating that the electric charge of
the silica side chain was altered by pH condition (Fig. 3C, right,
open circles), and that this value was higher than that of VLP
(Fig. 3C, left) throughout this pH range. After VP1 coating, however,
the z potential of silica beadswas 50mV at pH 5, 60mV at pH 7, and
40mV at pH 9 (Fig. 3C, right, closed circles). Taken together, these
ﬁndings show that VP1 pentamers can coat silica beads as well as
polystyrene beads.
3.4. VP1 coating of various types of artiﬁcial beads
To assess the effects of bead shape on VP1 coating, various types
and shapes of artiﬁcial beads were coated with VP1 pentamers.
Cubic magnetite beads, biodegradable PLGA beads, and liposomes
were incubated with VP1 pentamers, and their surfaces were
examined by TEM (Fig. 4). Following the VP1-coating reaction,
cubic magnetite beads were well-dispersed and covered with
white monolayers (Fig. 4A, upper right panel) in contrast to
uncoated cubic magnetite beads (Fig. 4A, upper left panel). This
white monolayer was also observed on VP1-coated CMNPs [18],
suggesting that the cubic magnetite beads were also likely covered
by VP1 pentamers. Measurement of the average diameter in
solution of cubic magnetite beads before and after VP1 coating
showed that, consistent with the previous study of CMNPs [18],
VP1 coating greatly enhanced the mono-dispersibility of cubic
magnetite particles (Fig. 4A, lower panel), whereas uncoated cubic
magnetite beads clustered in large aggregates.
Uncoated PLGA beads were spherical just after preparation
(Fig. 4B, left) but formed a shriveled structure with irregular
surfaces after dialysis for 16h (Fig. 4B, center). By contrast, PLGA
beads coatedwith VP1 pentamersmaintained a spherical structure
with smooth surfaces (Fig. 4B, right). In addition, TEM showed that
liposomes were also covered by VP1 pentamers (Fig. 4C). These
results indicate that VP1 pentamers can coat various types of
artiﬁcial beads, even those with an irregular or angular structure.
4. Discussion
This study showed that VP1 pentamers of SV40 can coat various
particles, regardless of their size, shape, and z potential. Moreover,
coating or pretreatment of artiﬁcial beads was not necessary to
facilitate attachment of VP1 pentamers. To elucidate the surface
conditions required for VP1 coating, the ability of VP1 pentamers
to coat two types of artiﬁcial beads was assessed: polystyrene
beads with lower potential and silica beads with higher potential.
Surprisingly, EM showed that both types of beadswere coatedwith
VP1 pentamers. Moreover, the z potential of coated larger sized
[(Fig._4)TD$FIG]
Fig. 4. VP1 coating of various types of artiﬁcial beads. A, cubicmagnetite beadswere incubatedwith (upper right panel) or without (upper left panel) VP1 pentamers during
dialysis. The samples were visualized by TEM with negative staining. Scale bars: 100nm or 25nm (insets). Average diameter of cubic magnetite beads in solution (lower
panel). Error bars show one standard deviation. B, PLGA beads (left) were incubated with (right) or without (center) VP1 pentamers during dialysis. The samples were
visualized by TEMwith negative staining. Scale bars: 200nmor 100nm (insets). C, liposomeswere incubatedwith (right) orwithout (left) VP1 pentamers during dialysis. The
samples were visualized by TEM with negative staining. Scale bars: 100nm or 25nm (insets).
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beads was close to that of 45nm VLP, indicating that
VP1 pentamers covered these beads. In addition to polystyrene
and silica beads, VP1 pentamers were capable of coating cubic
magnetite and rough-surfaced liposomes.
Immobilization of a viral RNA sequence onto the artiﬁcial beads
was found to be necessary for bead coating by a capsid protein of
RCNMV [15]. VP1-pentamer coating, however, did not require
speciﬁc bead modiﬁcations [16]. Moreover, SV40 VP1 pentamers
could coat artiﬁcial beads larger than wild-type SV40 capsid.
VP1 pentamers may be able to self-reassemble, such that
puriﬁed VP1 pentamers could automatically reassemble into VLPs
without the need of any cellular factors [19]. In the presence of
double-stranded DNA, puriﬁed VP1 pentamers formed a capsid
structure 45nm in diameter [8]. During this process,
VP1 pentamers attached to DNA molecules, followed by
construction of the encapsidating icosahedral capsid structure.
Furthermore, CMNPs (8,10, and 27nm in diameter)were coated by
self-reassembling VP1 pentamers [18]. The C-terminal region of
VP1 was found to be critical for the complete coverage of CMNPs
by VP1 pentamers because loss of this region resulted in
the nonspeciﬁc attachment of VP1 pentamers to CMNPs and
incomplete coverage of CMNPs, as well as an inability of
VP1 pentamers to form the capsid structure [20,21]. Based on
these results, we hypothesize that self-assembly of VP1 pentamers
through their C-terminal region plays an important role in
VP1 coating of the materials described in the current study.
One of the reasons that SV40 VP1 pentamers successfully
coated various materials in this study was likely due to the use of
gel-ﬁltered monomeric VP1 pentamers. Gel ﬁltrationwas found to
yield two VP1 peaks, corresponding to the void volume (>670kDa)
and approximately 200kDa [2,4,5], indicating that VP1 pentamers
are present as both multimeric and monomeric forms after
dissociation in the presence of EGTA and DTT. In this study, gel-
ﬁltered dissociated VP1 pentamers were used to coat various
particles. According to the quasi equivalence theory for the
development of icosahedral lattices [22], any icosahedral sym-
metric structures can be constructed with ﬁve-fold pentameric
units and six-fold hexameric units. For example, a triangulation
number 1 icosahedral lattice consists of 12 ﬁve-fold pentameric
units; a triangulation number 3 lattice consists of 12 ﬁve-fold
pentameric units plus 20 six-fold hexameric units; and a T =7d
icosahedral lattice, such as the SV40 capsid, consists of 12 ﬁve-fold
pentameric units plus 60 six-fold hexameric units. Crystallography
of the SV40 capsid shows that VP1 pentamers are present as both
ﬁve-fold pentameric and six-fold hexameric units in the icosahe-
dral lattice [1,23]. Since monomeric VP1 pentamers can be present
in bothﬁve-fold and six-fold positions, the SV40 icosahedral capsid
is formed by VP1 pentamers alone. One of the beneﬁts of utilizing
monomeric VP1 pentamers may be their ability to form both ﬁve-
fold pentameric units and six-fold pentameric units on the
icosahedral lattice. Therefore, we hypothesize that monomeric
VP1 pentamers could be located at any position on artiﬁcial beads,
even when forming icosahedral lattices larger than the wild-type
SV40 capsid. In addition toVP1 coating of the larger artiﬁcial beads,
cubic beads and rough-shaped liposome beads could also be
coated by monomeric VP1 pentamers, suggesting that these
pentamers are sufﬁciently ﬂexible to coat various shaped artiﬁcial
beads by adjusting the spacing and curvature between these
pentamers, depending on the surface structure of the artiﬁcial
beads. VP1-coated cubic magnetite beads retained their cubic
structure, indicating that the VP1 pentamers adjusted their
positioning. Thus, VP1-pentamer coating of liposomes may alter
them from amorphous rounded particles to regular faceted
particles on ﬂuid surface of liposomes. Although VP1 pentamers
may adjust their coordination on artiﬁcial beads, the interactions
between VP1 pentamers, and adjustment of their spacing and
curvature on beads during VP1 coating, remain unclear but may be
revealed by real-time atomic force microscopy.
Finally, coating of artiﬁcial materials with VP1 pentamers may
improve their mono-dispersibility and stability. VP1-coated
CMNPs were monodispersed in physiological and serum
containing buffers, whereas uncoated CMNPs clustered and
formed large multimeric structures [18]. Monodispersity of
VP1-coated CMNPs enhanced the retention of these particles in
body ﬂuids of mice, as well as improving their targeting activity
[18]. Moreover, SV40 VLPs retained their capsid structure even
after incubation at 50 C for 1h in the presence of calcium
chloride [24]. Therefore, VP1 coating may improve the structural
stability of fragile materials such as liposomes, which are easily
disrupted in bodyﬂuids. Thus, VP1 coating has potential for various
applications in drug delivery.
5. Conclusion
This report showed thatmonomeric SV40VP1 pentamers coat a
variety of artiﬁcial beads, regardless of size and shape, due to their
self-reassembly activity. VP1-coatedmaterials may not only have a
capsid-like surface but bemono-dispersible and stable, whichmay
enhance their retention in body ﬂuids and cell-targeting properties
when used for drug delivery.
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